Characteristics | All | Neurocognitively unimpaired N (%) | Neurocognitively impaired N (%) | p value |
---|---|---|---|---|
Demographics | ||||
Age [years, M (S.D.)]a | 43.6 (09.6) | – | – | 0.04 |
Genderb | ||||
Male [N (%)] | 72 (74.2) | 23 (31.9) | 49 (68.1) | 0.26 |
Female [N (%)] | 25 (25.8) | 05 (20.0) | 20 (80.0) | |
Socioeconomic status [Kuppuswamy Scale] [N (%)]c | ||||
Lower | 02 (02.1) | 00 (00.0) | 02 (100.0) | 0.21 |
Upper lower | 70 (72.2) | 18 (25.7) | 52 (74.3) | |
Lower middle | 18 (18.6) | 07 (38.9) | 11 (61.1) | |
Upper middle | 07 (07.2) | 03 (42.9) | 04 (57.1) | |
Upper | 00 (00.0) | 00 (00.0) | 00 (00.0) | |
No. of years of education [M (S.D.)]a | 10.9 (04.4) | – | – | 0.68 |
Psychiatric characteristics [N (%)] | ||||
Mood symptoms (Based on Beck’s Depression Inventory)c | ||||
Normal | 89 (91.8) | 49 (55.1) | 40 (44.9) | 0.78 |
Mild mood disturbances | 08 (08.2) | 05 (62.5) | 03 (37.5) | |
HIV disease characteristics | ||||
CD4 cell count [M (S.D.)]a | 466.6 (189.2) | – | – | 0.11 |
Nadir CD4 cell count [M (S.D.)]a | 185 (54.1) | – | – | 0.22 |
Diagnosed with AIDs [N (%)]c | – | – | ||
Yes | 13 (13.4) | 00 (00.0) | 13 (100.0) | 0.98 |
No | 84 (86.6) | 28 (33.3) | 56 (66.7) | |
Time since HIV diagnosis [M (S.D.)]a | 08.4 (02.1) | - | - | 0.67 |
ART statusc | ||||
On ART [N (%)] | 95 (97.9) | 27 (28.4) | 68 (71.6) | 0.58 |
Not on ART [N (%)] | 02 (02.1) | 01 (50.0) | 01 (50.0) | |
Duration of ART (years) [M (S.D.)]a | 2.6 (1.9) | – | – | 0.94 |
Efavirenz-based treatment regimenb | ||||
N (%) On Efavirenz | 49 (50.5) | 14 (28.6) | 35 (71.4) | 0.79 |
N (%) Not on Efavirenz | 46 (49.5) | 12 (26.1) | 34 (73.9) | |
ART regimen [N (%)] | ||||
TDF + 3TC + EFV | 49 (50.5) | – | – | |
AZT + 3TC + NVP | 39 (40.2) | – | – | |
AZT + 3TC + LPV/r | 02 (02.1) | – | – | |
AZT + 3TC + ABC | 02 (02.1) | – | – | |
TDF + 3TC + ABC | 02 (02.1) | – | – | |
TDF + 3TC + LPV/r | 01 (01.0) | – | – |